Ja Min Byun

Scopus Author ID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 28

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Nature communications

Therapeutic advances in hematology

Journal of Korean medical science

Seoul National University Hospital

Seoul National University College of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Seoul National University Hospital Jun 01 2019

South Korea

Clinical Assistant Professor :: Internal Medicine

Seoul National University Seoul Metropolitan Government Boramae Medical Center Mar 01 2017 - May 31 2019

South Korea

Clinical Assistant Professor :: Division of Hematology and Medical Oncology, Dept of Internal Medicine

Seoul National University Hospital Mar 01 2015 - Feb 28 2017

South Korea

Clinical fellow :: Hematology and Medical Oncology

Kyung Hee University Hospital Mar 01 2011 - Feb 28 2015

South Korea

Resident :: Internal Medicine

Education History

Seoul National University College of Medicine - Feb 28 2019

South Korea

PHD :: Translation medicine-hematology

Publications

Naresh Bumma, Joshua Richter, Sundar Jagannath, Hans C Lee, James E Hoffman, Attaya Suvannasankha, Jeffrey A Zonder, Mansi R Shah, Suzanne Lentzch, Rachid C Baz, Joseph J Maly, Swathi Namburi, Matthew J Pianko, Jing Christine Ye, Ka Lung Wu, Rebecca W Silbermann, Chang-Ki Min, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquin Martinez Lopez, Kaniel Cassady, Michelle DeVeaux, Dhruti Chokshi, Anita Boyapati, Anasuya Hazra, George D Yancopoulos, L Andres Sirulnik, Karen Rodriguez Lorenc, Glenn S Kroog, Yariv Houvras, Madhav V Dhodapkar
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Naresh Bumma, Joshua Richter, Sundar Jagannath, Hans C Lee, James E Hoffman, Attaya Suvannasankha, Jeffrey A Zonder, Mansi R Shah, Suzanne Lentzch, Rachid C Baz, Joseph J Maly, Swathi Namburi, Matthew J Pianko, Jing Christine Ye, Ka Lung Wu, Rebecca W Silbermann, Chang-Ki Min, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquin Martinez Lopez, Kaniel Cassady, Michelle DeVeaux, Dhruti Chokshi, Anita Boyapati, Anasuya Hazra, George D Yancopoulos, L Andres Sirulnik, Karen Rodriguez Lorenc, Glenn S Kroog, Yariv Houvras, Madhav V Dhodapkar
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Changhee Park, Ho Sup Lee, Byung Soo Kim, Won-Sik Lee, Young Rok Do, Jae-Yong Kwak, Ho-Jin Shin, Sung-Yong Kim, Jun Ho Yi, Sung-Nam Lim, Jeong-Ok Lee, Deok Hwan Yang, Hun Jang, Byoungsan Choi, Jiwoo Lim, Choong Hyun Sun, Ja Min Byun, Sung Soo Yoon, Youngil Koh
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial. Nature communications 15 (1) (2024)
Changhee Park, Ho Sup Lee, Byung Soo Kim, Won-Sik Lee, Young Rok Do, Jae-Yong Kwak, Ho-Jin Shin, Sung-Yong Kim, Jun Ho Yi, Sung-Nam Lim, Jeong-Ok Lee, Deok Hwan Yang, Hun Jang, Byoungsan Choi, Jiwoo Lim, Choong Hyun Sun, Ja Min Byun, Sung Soo Yoon, Youngil Koh
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial. Nature communications 15 (1) (2024)
Changhee Park, Ho Sup Lee, Byung Soo Kim, Won-Sik Lee, Young Rok Do, Jae-Yong Kwak, Ho-Jin Shin, Sung-Yong Kim, Jun Ho Yi, Sung-Nam Lim, Jeong-Ok Lee, Deok Hwan Yang, Hun Jang, Byoungsan Choi, Jiwoo Lim, Choong Hyun Sun, Ja Min Byun, Sung Soo Yoon, Youngil Koh
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial. Nature communications 15 (1) (2024)
Naresh Bumma, Joshua Richter, Sundar Jagannath, Hans C Lee, James E Hoffman, Attaya Suvannasankha, Jeffrey A Zonder, Mansi R Shah, Suzanne Lentzch, Rachid C Baz, Joseph J Maly, Swathi Namburi, Matthew J Pianko, Jing Christine Ye, Ka Lung Wu, Rebecca W Silbermann, Chang-Ki Min, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquin Martinez Lopez, Kaniel Cassady, Michelle DeVeaux, Dhruti Chokshi, Anita Boyapati, Anasuya Hazra, George D Yancopoulos, L Andres Sirulnik, Karen Rodriguez Lorenc, Glenn S Kroog, Yariv Houvras, Madhav V Dhodapkar
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Changhee Park, Ho Sup Lee, Byung Soo Kim, Won-Sik Lee, Young Rok Do, Jae-Yong Kwak, Ho-Jin Shin, Sung-Yong Kim, Jun Ho Yi, Sung-Nam Lim, Jeong-Ok Lee, Deok Hwan Yang, Hun Jang, Byoungsan Choi, Jiwoo Lim, Choong Hyun Sun, Ja Min Byun, Sung Soo Yoon, Youngil Koh
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial. Nature communications 15 (1) (2024)
Changju Chun, Ja Min Byun, Minkwon Cha, Hong-Won Lee, Byungsan Choi, Hyunwoo Kim, Saem Hong, Yunseo Lee, Hayoung Park, Youngil Koh, Tae-Young Yoon
Profiling protein-protein interactions to predict the efficacy of B-cell-lymphoma-2-homology-3 mimetics for acute myeloid leukaemia. Nature biomedical engineering (2024)
Dong Hyun Kim, Junshik Hong, Dong-Yeop Shin, Inho Kim, Sung Soo Yoon, Soo Mee Bang, Jeong-Ok Lee, Ji Yun Lee, Sang-A Kim, Ja Min Byun, Youngil Koh
Phase II trial of posaconazole prophylaxis during anti-thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome. British journal of haematology 205 (1) (2024)
Naresh Bumma, Joshua Richter, Sundar Jagannath, Hans C Lee, James E Hoffman, Attaya Suvannasankha, Jeffrey A Zonder, Mansi R Shah, Suzanne Lentzch, Rachid C Baz, Joseph J Maly, Swathi Namburi, Matthew J Pianko, Jing Christine Ye, Ka Lung Wu, Rebecca W Silbermann, Chang-Ki Min, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquin Martinez Lopez, Kaniel Cassady, Michelle DeVeaux, Dhruti Chokshi, Anita Boyapati, Anasuya Hazra, George D Yancopoulos, L Andres Sirulnik, Karen Rodriguez Lorenc, Glenn S Kroog, Yariv Houvras, Madhav V Dhodapkar
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (22) (2024)
Dong Hyun Kim, Junshik Hong, Dong-Yeop Shin, Inho Kim, Sung Soo Yoon, Soo Mee Bang, Jeong-Ok Lee, Ji Yun Lee, Sang-A Kim, Ja Min Byun, Youngil Koh
Phase II trial of posaconazole prophylaxis during anti-thymocyte globulin treatment for aplastic anaemia and hypoplastic myelodysplastic syndrome. British journal of haematology (2024)
Jun Liu, Suji Min, Dongchan Kim, Jihyun Park, Eunchae Park, Shanshan Pei, Youngil Koh, Dong-Yeop Shin, Ja Min Byun, Myunggon Ko, Sung Soo Yoon, Junshik Hong
Pharmacological GLUT3 salvage augments the efficacy of vitamin C-induced TET2 restoration in acute myeloid leukemia. Leukemia (2023)
Eun Hee Jung, Ja Min Byun, Dong-Yeop Shin, Young Rok Do, Jae-Cheol Jo, Sang Min Lee, Sung Soo Yoon
Mobilization of hematopoietic stem cells with lenograstim in multiple myeloma patients: Prospective multicenter observational study (KMM122). Cancer medicine (2023)
Nan Young Bae, Ja Min Byun, Chang Kyung Kang, Pyoeng Gyun Choe, Nam Joong Kim, Min-Sung Kim, Kyu Joo Park, Sung-Soo Yoon
Successful treatment of angioinvasive aspergillosis causing diaphragmatic rupture with bowel perforation and cerebral aspergillosis in a patient with FLT3-mutated acute myeloid leukemia: A case report. Medicine 101 (4) (2022)
Hyun Jin Ahn, Ja Min Byun, Inho Kim, Jeonghwan Youk, Youngil Koh, Dong-Yeop Shin, Junshik Hong, Sung Soo Yoon
Eltrombopag for Post-Transplant Poor Graft Function in East Asian Patients. Journal of Korean medical science 37 (6) (2022)
Hyunkyung Park, Ja Min Byun, Sung Soo Yoon, Youngil Koh, Sock-Won Yoon, Dong-Yeop Shin, Junshik Hong, Inho Kim
Cyclophosphamide addition to pomalidomide/dexamethasone is not necessarily associated with universal benefits in RRMM. PloS one 17 (1) (2022)
Ja Min Byun, Dong-Yeop Shin, Youngil Koh, Junshik Hong, Inho Kim, Sung-Soo Yoon, Soo-Mee Bang, Jeong-Ok Lee
Should patients receive consolidation chemotherapy before reduced intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission? Therapeutic advances in hematology 12 (2021)
Hyun Kyu Kim, Su Young Son, Jae Sang Oh, Ye Na Song, Ja Min Byun, Youngil Koh, Junshik Hong, Sung Soo Yoon, Choong Hwan Lee, Dong-Yeop Shin, Man-Ryul Lee
Metabolic Profiling during Acute Myeloid Leukemia Progression Using Paired Clinical Bone Marrow Serum Samples. Metabolites 11 (9) (2021)
Song Lee Bak, Dong-Yeop Shin, Junshik Hong, Inho Kim, Youngil Koh, Ja Min Byun, Sung-Soo Yoon
Busulfan plus melphalan versus melphalan alone conditioning regimen after bortezomib based triplet induction chemotherapy for patients with newly diagnosed multiple myeloma. Therapeutic advances in hematology 12 (2021)
Jeongmin Seo, Dong-Yeop Shin, Youngil Koh, Inho Kim, Sung-Soo Yoon, Ja Min Byun, Junshik Hong
Association between preconditioning absolute lymphocyte count and transplant outcomes in patients undergoing matched unrelated donor allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning and anti-thymocyte globulin. Therapeutic advances in hematology 12 (2021)
Ja Min Byun, Junshik Hong, Doyeun Oh, Ho-Young Yhim, Young Rok Do, Joon Seong Park, Chul Won Jung, Deok-Hwan Yang, Jong-Ho Won, Hong Ghi Lee, Joon Ho Moon, Yeung-Chul Mun, Deog-Yeon Jo, Jae Joon Han, Je-Hwan Lee, Jae Hoon Lee, Junglim Lee, Sung Soo Yoon
Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid Leukemia. Journal of clinical medicine 9 (7) (2020)
Sung Soo Park, Ja Min Byun, Sung Soo Yoon, Kihyun Kim, Sung Hoon Jung, Je-Jung Lee, Chang-Ki Min
Daratumumab monotherapy for relapsed/refractory multiple myeloma, focussed on clinical trial-unfit patients and subsequent therapy. British journal of haematology 193 (1) (2020)
Ja Min Byun, Sung-Soo Yoon, Youngil Koh, Chang-Ki Min, Jae Hoon Lee, Jaemin Jo, Hyunkyung Park, Jiyun Lee, Ka-Won Kang, Yoojin Lee, null null
Incorporating hematopoietic stem-cell transplantation after second-line carfilzomib-lenalidomide-dexamethasone (KRd). Therapeutic advances in hematology 11 (2020)
Hoi Soo Yoon, Yujin Han, Young-Jin Kim, Min Jin Kim, Ja Min Byun, Tae-Mi Youk, Jae Hee Lee, Tae Sung Park, Jongha Yoo
Epidemiology of Congenital Bleeding Disorders: a Nationwide Population-based Korean Study. Journal of Korean medical science 35 (39) (2020)
Hyunkyung Park, Ja Min Byun, Sung Soo Yoon, Youngil Koh, Dong-Yeop Shin, Junshik Hong, Inho Kim
Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant? (Running Title: The Role of Salvage alloSCT in MM). Journal of clinical medicine 9 (8) (2020)
Ja Min Byun, Young Nam Kwon, Youngil Koh, Sung-Soo Yoon, Jung-Joon Sung, Inho Kim
Distinctive patterns of peripheral neuropathy across the spectrum of plasma cell disorders. Scientific reports 9 (1) (2019)
Ja Min Byun, Dong-Yeop Shin, Junshik Hong, Inho Kim, Hyun Kyung Kim, Dong Soon Lee, Youngil Koh, Sung-Soo Yoon
Distinct predictive impact of FISH abnormality in proteasome inhibitors and immunomodulatory agents response: redefining high-risk multiple myeloma in Asian patients. Cancer medicine 7 (3) (2018)
Ja Min Byun, Hea-Lim Kim, Dong-Yeop Shin, Youngil Koh, Sung-Soo Yoon, Moon-Woo Seong, Sung Sup Park, Jin Hee Kim, Yun-Gyoo Lee, Inho Kim
The Impact of Methylenetetrahydrofolate Reductase C677T Polymorphism on Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Methotrexate Prophylaxis. PloS one 11 (10) (2016)
Ja Min Byun, Chang Kyun Lee, Sang Youl Rhee, Hyo Jong Kim, Jung Wook Kim, Jae-Jun Shim, Jae Young Jang
The risk of tuberculosis in Korean patients with inflammatory bowel disease receiving tumor necrosis factor-α blockers. Journal of Korean medical science 30 (2) (2015)

Ja Min Byun.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ja Min Byun